Cargando…

The impact of bDMARDs on postoperative complications in patients with rheumatoid arthritis: A systematic review and meta-analysis

BACKGROUND: The influence of biological disease-modifying antirheumatic drugs (bDMARDs) on postoperative surgical site infection (SSI) and venous thromboembolism (VTE) in patients with rheumatoid arthritis (RA) has not yet been clarified. METHODS: A systematic literature search was performed using P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suto, Takahito, Okamura, Koichi, Sakane, Hideo, Okura, Chisa, Kaneko, Tetsuya, Chikuda, Hirotaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	6900
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681505/ https://www.ncbi.nlm.nih.gov/pubmed/38013343 http://dx.doi.org/10.1097/MD.0000000000036132

Ejemplares similares

Real-world comparative effectiveness of bDMARDs and JAK inhibitors in elderly patients with rheumatoid arthritis
por: Temmoku, Jumpei, et al.
Publicado: (2022)

Prediction of Large Joint Destruction in Patients With Rheumatoid Arthritis Using (18)F-FDG PET/CT and Disease Activity Score
por: Suto, Takahito, et al.
Publicado: (2016)

Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates
por: Kaneko, Tetsuya, et al.
Publicado: (2019)

Does periodontitis affect the treatment response of biologics in the treatment of rheumatoid arthritis?
por: Tachibana, Masahiro, et al.
Publicado: (2020)

Anti-drug antibodies and rheumatoid factor level in patients with rheumatoid arthritis using the infliximab biosimilar CT-P13
por: Sakane, Hideo, et al.
Publicado: (2022)

Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
por: Trang, D. A. M. Thuy, et al.
Publicado: (2021)

High remission and low relapse with prolonged intensive DMARD therapy in rheumatoid arthritis (PRINT): A multicenter randomized clinical trial
por: Li, Ru, et al.
Publicado: (2016)

Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study
por: Floris, Alberto, et al.
Publicado: (2021)

Risk of infection in postmenopausal women with rheumatoid arthritis and osteoporosis taking denosumab and bDMARDS
por: Mirzaei, Alireza, et al.
Publicado: (2021)

bDMARD Dose Reduction in Rheumatoid Arthritis: A Narrative Review with Systematic Literature Search
por: Verhoef, Lise M., et al.
Publicado: (2017)

Shoulder tenderness was associated with the inflammatory changes on magnetic resonance imaging in patients with rheumatoid arthritis
por: Shinagawa, Satoshi, et al.
Publicado: (2019)

Machine learning-based prediction model for responses of bDMARDs in patients with rheumatoid arthritis and ankylosing spondylitis
por: Lee, Seulkee, et al.
Publicado: (2021)

Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis
por: Gerardi, Maria Chiara, et al.
Publicado: (2022)

Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs)
por: Adami, Giovanni, et al.
Publicado: (2023)

Effects of bDMARDs on quality of life in patients with psoriatic arthritis: meta-analysis
por: Lu, Yuqiong, et al.
Publicado: (2022)

Use of a bDMARD or tsDMARD for the management of inflammatory arthritis under checkpoint inhibitors: an observational study
por: De La Fuente, Fanny, et al.
Publicado: (2022)

Outcomes with Biological Disease-Modifying Anti-Rheumatic Drugs (bDMARDs) in Older Patients Treated for Rheumatoid Arthritis
por: Akter, Ripa, et al.
Publicado: (2020)

Incident and recurrent herpes zoster for first-line bDMARD and tsDMARD users in seropositive rheumatoid arthritis patients: a nationwide cohort study
por: Jeong, Seogsong, et al.
Publicado: (2022)

Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate for Thai rheumatoid arthritis patients with high disease activity
por: Prawjaeng, Juthamas, et al.
Publicado: (2023)

Efficacy and Treatment Costs of Monotherapy with bDMARDs in the Treatment of Rheumatoid Arthritis in Patients Intolerant to or Inappropriate to Continue Treatment with Methotrexate
por: Batticciotto, Alberto, et al.
Publicado: (2016)

Improvement of HbA1c in Patients with Type 2 Diabetes Mellitus and Rheumatoid Arthritis Treated with bDMARDs
por: Lurati, Alfredomaria, et al.
Publicado: (2021)

Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs)
por: Adami, Giovanni, et al.
Publicado: (2023)

Prevalence of Undiagnosed Diabetes in Rheumatoid Arthritis: an OGTT Study
por: Ursini, Francesco, et al.
Publicado: (2016)

HBV and targeted synthetic (ts)DMARDs: what have we learned from bDMARDs and tsDMARDs?
por: Gremese, Elisa, et al.
Publicado: (2020)

In Antisynthetase Syndrome, ACPA Are Associated With Severe and Erosive Arthritis: An Overlapping Rheumatoid Arthritis and Antisynthetase Syndrome
por: Meyer, Alain, et al.
Publicado: (2015)

The coexistence of SAPHO syndrome and rheumatoid arthritis: A case report
por: Xu, Wenrui, et al.
Publicado: (2017)

Identification of key genes associated with rheumatoid arthritis with bioinformatics approach
por: Gang, Xiaokun, et al.
Publicado: (2017)

Resistin polymorphisms are associated with rheumatoid arthritis susceptibility in Chinese Han subjects
por: Wang, Lihong, et al.
Publicado: (2018)

Effectiveness of resistance exercises in the treatment of rheumatoid arthritis: A meta-analysis
por: Wen, Zhigang, et al.
Publicado: (2021)

Identifying the hub genes and immune infiltration related to pyroptosis in rheumatoid arthritis
por: Xie, Wei, et al.
Publicado: (2021)

Meta-analysis of risk factors for cardiovascular disease in patients with rheumatoid arthritis
por: Lyu, Qian, et al.
Publicado: (2023)

Comment on “Efficacy and Treatment Costs of Monotherapy with bDMARDs in the Treatment of Rheumatoid Arthritis in Patients Intolerant to or Inappropriate to Continue Treatment with Methotrexate”
por: Ravasio, Roberto
Publicado: (2017)

4β‐Hydroxycholesterol Level in Patients With Rheumatoid Arthritis Before vs. After Initiation of bDMARDs and Correlation With Inflammatory State
por: Wollmann, BM, et al.
Publicado: (2016)

MTX optimization or adding bDMARD equally improve disease activity in rheumatoid arthritis: results from the prospective study STRATEGE
por: Gaujoux-Viala, Cécile, et al.
Publicado: (2021)

Utility of a simplified ultrasonography scoring system among patients with rheumatoid arthritis: A multicenter cohort study
por: Endo, Yushiro, et al.
Publicado: (2021)

Abatacept Improves Whole-Body Insulin Sensitivity in Rheumatoid Arthritis: An Observational Study
por: Ursini, Francesco, et al.
Publicado: (2015)

Increased incidence of rheumatoid arthritis in multiple sclerosis: A nationwide cohort study
por: Tseng, Chia-Chun, et al.
Publicado: (2016)

Circulating interleukin-6 and rheumatoid arthritis: A Mendelian randomization meta-analysis
por: Li, Bing, et al.
Publicado: (2016)

The efficacy of statins in the treatment of rheumatoid arthritis: A systematic review and meta-analysis
por: Ren, Conglin, et al.
Publicado: (2023)

Body Mass Index and Risk of Rheumatoid Arthritis: A Meta-Analysis of Observational Studies
por: Feng, Jian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_c9qm3oekrslboietg1ieu4rejh